Variant report
Variant | esv3315494 |
---|---|
Chromosome Location | chr17:15052427-15058525 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574948795 | chr17:15057604-15057605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575011211 | chr17:15057633-15057634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531852055 | chr17:15057643-15057644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs542347702 | chr17:15057664-15057665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs550704555 | chr17:15057689-15057690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7218737 | chr17:15057691-15057692 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs533249705 | chr17:15057734-15057735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs114467861 | chr17:15057752-15057753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566110896 | chr17:15057778-15057779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528829566 | chr17:15057806-15057807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548581997 | chr17:15057829-15057830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs568569645 | chr17:15057830-15057831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs149022561 | chr17:15057880-15057881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs74878933 | chr17:15057888-15057889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs185537325 | chr17:15057908-15057909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs116249555 | chr17:15057942-15057943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534489278 | chr17:15057955-15057956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545504873 | chr17:15057994-15057995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs189126419 | chr17:15058004-15058005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565139110 | chr17:15058018-15058019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181673715 | chr17:15058041-15058042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs117075079 | chr17:15058078-15058079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567779922 | chr17:15058107-15058108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576610500 | chr17:15058109-15058110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs562540604 | chr17:15058112-15058113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs16951092 | chr17:15058117-15058118 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs370358044 | chr17:15058125-15058126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs55849802 | chr17:15058128-15058129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7222030 | chr17:15058145-15058146 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs187314287 | chr17:15058177-15058178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs74579553 | chr17:15058186-15058187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192222548 | chr17:15058189-15058190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs113882639 | chr17:15058219-15058220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs1122073 | chr17:15058236-15058237 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs5819508 | chr17:15058271-15058272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1122074 | chr17:15058273-15058274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs182726777 | chr17:15058335-15058336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs185063676 | chr17:15058387-15058388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs568305229 | chr17:15058489-15058490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs715192 | chr17:15058525-15058526 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21509527 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Autism | 17322880 | CNVD |
Hereditary neuropathy with liability to pressure palsy | 19521722 | CNVD |
Schizophrenia | 19571808 | CNVD |
Schizophrenia | 19955444 | CNVD |
Charcot-marie-tooth disease | 18787571 | CNVD |
Breast cancer | 20409316 | CNVD |
Autism | 18414403 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Peripheral neuropathy | 21193943 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 22958593 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Breast cancer | 21858162 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Schizophrenia | 20967226 | CNVD |
Autism | 18522746 | CNVD |
Epilepsy | 21635232 | CNVD |
Autism | 22543975 | CNVD |
Obesity | 20622171 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17142309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:15057600-15059000 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr17:15058000-15058800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
3 | chr17:15058000-15060800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr17:15058000-15061200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
5 | chr17:15058200-15058600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
6 | chr17:15058200-15058800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr17:15058200-15058800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr17:15058200-15059200 | Enhancers | Osteobl | bone |
9 | chr17:15058200-15059600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
10 | chr17:15058400-15058800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr17:15058400-15059200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr17:15058400-15059400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |